Moreover, it has been a matter of debate which PAD isoform, PAD2 or PAD4, is the most efficient catalyst mediating the citrullination within and in the vicinity of PMNs or PBMCs, and in synovial fluid of RA patients. The gene discussed is PADI2; the disease is rheumatoid arthritis.